Effect of Motor Development, Motor Function and Electrophysiologic Findings of IOPD Under ERT

T

Taipei Veterans General Hospital

Status

Unknown

Conditions

Glycogen Storage Disease Type II

Treatments

Other: observation study

Study type

Observational

Funder types

Other

Identifiers

NCT02761421
2015-12-014C

Details and patient eligibility

About

To investigate the motor development, motor function and electrodiagnostics presentation in IOPD under ERT.

Full description

Background Pompe disease is an autosomal recessive disease, enzyme replacement therapy (ERT) and new born screen (NBS) had been initiated in Taiwan since 2008. However, residual muscle weakness were noted. Decrease in amplitude of nerve compound muscle action potential (CMAP) and increase spontaneous activity were reported before the imitation of ERT. However, the motor development, motor function and electrodiagnostic presentation which were important in further direction of treatment and rehabilitation program arrangement in infantile Pompe disease (IOPD) under ERT is lacking. Aim To investigate the motor development, motor function and electrodiagnostic presentation in IOPD under ERT. Method This is an observational, prospective, longitudinal, follow-up study. Motor development was assessed by Alberta Infant Motor Scale (AIMS) and Peabody Developmental Motor Scales, Second Edition (PDMS II); motor function was assessed by Pediatric Evaluation of Disability Inventory (PEDI) and Gross Motor Function Measure (GMFM). Electrodiagnosis studies include nerve conduction study (NCS) and electromyography (EMG). Expect Effects Obtain the characteristics of motor development, motor function and electrodiagnosis presentation of IOPD under ERT, and the relation between motor development, motor function and electrodiagnosis presentation.

Enrollment

15 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

All patients with infantile onset Pompe disease (IOPD) who were diagnosed and follow-up at Taipei Veteran General Hospital (TVGH).

Exclusion criteria

Patients whose guardian did not provide the inform consent.

Trial design

15 participants in 1 patient group

patients with IOPD
Description:
observation all patients with IOPD
Treatment:
Other: observation study

Trial contacts and locations

1

Loading...

Central trial contact

chihjou lai

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems